1. Home
  2. FULC vs TRVG Comparison

FULC vs TRVG Comparison

Compare FULC & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.88

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Logo trivago N.V.

TRVG

trivago N.V.

SELL

Current Price

$5.59

Market Cap

375.4M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
FULC
TRVG
Founded
2015
2005
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
467.8M
375.4M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
FULC
TRVG
Price
$3.88
$5.59
Analyst Decision
Buy
Hold
Analyst Count
8
6
Target Price
$16.38
$3.95
AVG Volume (30 Days)
1.5M
77.6K
Earning Date
04-27-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.59
Revenue Next Year
N/A
$8.42
P/E Ratio
N/A
$16.98
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$2.59
52 Week High
$15.74
$5.78

Technical Indicators

Market Signals
Indicator
FULC
TRVG
Relative Strength Index (RSI) 49.05 58.23
Support Level $3.41 $2.76
Resistance Level $4.02 $5.72
Average True Range (ATR) 0.15 0.36
MACD 0.05 -0.05
Stochastic Oscillator 82.19 65.06

Price Performance

Historical Comparison
FULC
TRVG

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

Share on Social Networks: